Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOBUPIVACAINE vs LEVOKETOCONAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOBUPIVACAINE vs LEVOKETOCONAZOLE: Safety Overview

Metric LEVOBUPIVACAINE LEVOKETOCONAZOLE
Total FAERS Reports 395 309
Deaths Reported 12 8
Death Rate 3.0% 2.6%
Hospitalizations 150 99
Average Patient Age 52.5 yrs 54.8 yrs
% Female Patients 71.7% 86.3%
FDA Approval Date Aug 5, 1999 Dec 30, 2021
Manufacturer N/A Xeris Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status Discontinued Prescription